Feb 25 2010
Agilent Technologies Inc. (NYSE:A) today announced that its Agilent
SureSelect Target Enrichment System supports multiplexed DNA
sequencing of 12 to 16 samples per lane depending on the next-generation
sequencing platform, reducing costs and increasing throughput up to
16-fold.
“Agilent SureSelect’s new multiplexing capability extends this benefit
by dramatically reducing costs and significantly increasing throughput
without sacrificing data quality.”
“We originally designed the Agilent SureSelect Target Enrichment System
to enable geneticists to efficiently analyze larger numbers of samples
by sequencing just the genomic regions of interest,” said Fred Ernani,
Ph.D., Agilent marketing manager, Emerging Genomic Applications.
“Agilent SureSelect’s new multiplexing capability extends this benefit
by dramatically reducing costs and significantly increasing throughput
without sacrificing data quality.”
Protocols are robust and easy to follow, enabling multiple samples to be
run together, but their data to be analyzed separately. The kits are
optimized for the Illumina Genome Analyzer and the Applied Biosystems
SOLiD platform. The Illumina can sequence 12 samples per lane for a
total of 96 samples per run. The SOLiD platform can sequence 16 samples
per quadrant or octet, allowing up to 256 samples to be processed per
run.
The first Agilent SureSelect products available with multiplexing
capabilities are custom kits designed with eArray; Agilent’s Web-based
microarray and the Agilent SureSelect design tool. The kits are packaged
in a variety of sizes, ranging from 10 to 5,000 reactions per custom
kit. Having kits of different sizes allows researchers to use the same
technology for small initial investigations as well as large profiling
studies, all with the same product format that is amenable to
automation. New kits composed of predefined content will be available in
multiplexing format later this year.
“Several customers are testing Agilent SureSelect products supporting
indexing and barcoding, and are pleased with the performance they are
getting,” said Ernani.
The Agilent SureSelect Target Enrichment System, employing a method
licensed from the Broad Institute of Harvard and MIT, is now the
platform with the most optimized protocols for a diverse set of
sequencing protocols and platforms. It supports Illumina end-sequencing
and paired-end sequencing protocols in addition to fragment library
format sequencing on the SOLiD System. Users of Agilent’s eArray
online design tool can improve the efficiency of their research by
easily designing custom products to target any genome of interest, all
in a single tube.
SOURCE Agilent Technologies Inc.